These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8200408)

  • 21. [Effect of 131I-labeled recombinant human tumor necrosis factor-alpha on the nude mice bearing human hepatoma].
    Long YH; Li YC; Mi YX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):787-92. PubMed ID: 19950584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Advantages in combination chemotherapy using the camptothecin analogue CPT-11 and cisplatinum analogues for human testicular cancer xenografts].
    Miki T; Kotake T
    Hinyokika Kiyo; 1993 Dec; 39(12):1221-5. PubMed ID: 8285173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models.
    Rosenblum MG; Cheung L; Mujoo K; Murray JL
    Cancer Immunol Immunother; 1995 May; 40(5):322-8. PubMed ID: 7600565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
    Shirakawa T; Gotoh A; Zhang Z; Kao C; Chung LW; Gardner TA
    Urology; 2004 Mar; 63(3):613-8. PubMed ID: 15028478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha in combination against human cancer transplanted into nude mice.
    Naomoto Y; Tanaka N; Orita K
    Acta Med Okayama; 1989 Aug; 43(4):211-21. PubMed ID: 2801185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
    Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combined therapy of hyperthermia and tumor necrosis factor for nude mice bearing KK-47 bladder cancer.
    Amano T; Kumini K; Nakashima K; Uchibayashi T; Hisazumi H
    J Urol; 1990 Aug; 144(2 Pt 1):370-4. PubMed ID: 2374209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of a human renal cell carcinoma in nude mice with recombinant human tumor necrosis factor alpha and etoposide.
    Hofmockel G; Bassukas ID; Heimbach D; Wirth M; Maurer-Schultze B
    J Urol; 1993 Dec; 150(6):1974-9. PubMed ID: 8230548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
    Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
    Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r.
    Watanabe N; Niitsu Y; Yamauchi N; Umeno H; Sone H; Neda H; Urushizaki I
    J Biol Response Mod; 1988 Feb; 7(1):24-31. PubMed ID: 2453618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of vulva cancer responding to the recombinant human tumor necrosis factor (PT-950)--local injection therapy].
    Irie K; Satonaka K; Matsuura M; Miura Y; Nakayama H
    Gan No Rinsho; 1988 Jun; 34(7):946-50. PubMed ID: 3398264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined effect of TNF and anticancer chemotherapeutic agents on murine bladder tumor (MBT-2)].
    Ikemoto S; Iimori H; Nishimoto K; Hayahara N; Kamizuru M; Wada S; Hayahara M
    Hinyokika Kiyo; 1992 Mar; 38(3):285-9. PubMed ID: 1523983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of tumor necrosis factor alpha on a human renal cell carcinoma xenotransplanted into nude mice: comparison of intravenous and intraperitoneal injection.
    Hofmockel G; Bassukas ID; Heimbach D; Metz R; Wirth MP
    Oncology; 1995; 52(1):69-75. PubMed ID: 7800346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental studies on antitumor activity of new recombinant human tumour necrosis factor in nude mice bearing nasopharyngeal carcinoma].
    Dong W; Zhou R; Zhou S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Feb; 33(1):38-41. PubMed ID: 11498888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
    Bassukas ID; Hofmockel G; Maurer-Schultze B
    Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
    J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental studies on antitumor effect by the new recombinant tumour necrosis factor and cyclophosphamide in nude mice bearing laryngeal carcinoma].
    Dong W; Zhou S; Li Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 15(12):555-7. PubMed ID: 12541728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation of cytotoxic activity of recombinant human tumor necrosis factor (rHu-TNF) by recombinant human interferon-gamma (rHu-IFN-gamma).
    Taguchi T; Kimoto Y; Tanji Y; Abe S; Nakano K; Sohmura Y
    J Biol Response Mod; 1987 Dec; 6(6):599-609. PubMed ID: 3131488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.
    Kumazawa E; Jimbo T; Akimoto T; Joto N; Tohgo A
    Cancer Invest; 1997; 15(6):522-30. PubMed ID: 9412657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.